摘要
目的评估微波消融治疗早期小肺癌的疗效及安全性。方法选取山东省临沂市人民医院2019-06-01-2022-06-30收治的186例不能手术的早期小肺癌患者作为研究对象。其中,男84例,女102例,年龄47~84岁,共计205个病灶。回顾性分析患者临床资料,调查患者肺癌消融情况,记录病灶特征、不良反应及并发症发生情况。结果186例患者病灶均得到完全消融,无复发。205个病灶中,纤维索条174个(84.88%),空洞10个(4.88%),结节21个(10.24%)。并发症方面,气胸13例(6.99%),气胸伴皮下气肿3例(1.61%),痰中带血28例(15.05%),肺部感染7例(3.76%)。结论不能手术的早期小肺癌患者采用微波消融治疗后效果较好,且并发症较少,手术安全性高,可在临床上应用。
Objective To evaluate the efficacy and safety of microwave ablation in the treatment of early small lung cancer.Method Totally 186 early-stage non-surgical small lung cancer patients admitted to the People's Hospital of Linyi City,Shandong Province from June 1,2019 to June 30,2022 were selected as the study subjects.The patient clinical data was retrospective analyzed,including lung cancer ablation status,lesion characteristics,adverse reactions and incidence of complications.Result The lesions in 186 patients were completely ablated without recurrence.Among 205 lesions,there were 174 fibrous bands(84.88%),10 cavities(4.88%),and 21 nodules(10.24%).In terms of complications,there were 13 cases(6.99%)of pneumothorax,3 cases(1.61%)of pneumothorax with subcutaneous emphysema,28 cases(15.05%)of bloody sputum,and 7 cases(3.76%)of pulmonary infection.Conclusion Early stage small lung cancer patients who cannot undergo surgery can undergo complete ablation of the nodule lesions after microwave ablation treatment,with fewer complications and high surgical safety,which can be applied clinically.
作者
孟祥熙
陶蓉
MENG Xiangxi;TAO Rong(Linyi People's Hospital,Linyi,Shandong 276000,China)
出处
《中华肿瘤防治杂志》
CAS
北大核心
2024年第5期300-304,共5页
Chinese Journal of Cancer Prevention and Treatment
基金
山东省医药卫生科技发展计划(202003020869)。
关键词
肺癌
微波消融
并发症
介入治疗
lung cancer
microwave ablation
complications
interventional therapy